NFKB1 and Anxiety: E100 dose-dependently ameliorated repetitive and compulsive behaviors. Pretreatment with E100 attenuated anxiety levels, microglial activation, proinflammatory cytokine release and expression of NF-κB, iNOS, and COX-2 in the cerebellum.